1.1 property renewals to be stable, casualty rates may harden: AM Best
November 21 2024 by Joana Nguyen
-
Trebling of ‘nuclear’ verdicts in US challenges liability underwriters: Allianz
- November 20
Apart from social inflation, the increasing complexity of pharma class actions, PFAS litigation and the growth of collective redress outside of the US are among the other trends creating difficulties for carriers, according to the report.
-
AIG Singapore promotes Vanessa Yeo to head of casualty
- November 20
Before assuming her new role, Yeo was casualty lead for the broker distribution channel.
-
US exposures, climate change, pricing challenges weigh on APAC casualty underwriters
- November 15
The casualty market faces challenges in predicting risks due to global interconnectedness and emerging threats like PFAS and cyber.
-
Specialty growth, Australia, Dubai operations fire up Markel’s APAC growth
- November 1
The Lloyd’s player, set to grow premiums by 40% in 2024, is seeing strong demand for the war, renewable energy, and casualty classes in the region, says Christian Stobbs.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
